Active ingredient

Registrations named Fosfomycin

Fosfomycin is an active ingredient, not a brand name. 12 registrations in the DRAP register carry it in the product name, and the price index attributes them to 2 manufacturers — these are generic products, not one company's range.

Registrations
12
Manufacturers
2
Dosage forms
Injection · Capsule · Suspension · Syrup
Approved price range
Rs 150.10 – Rs 295.92

Registrations

Registered nameReg. No.StrengthFormManufacturerPrice from
FOSFOMYCIN 4MG INJ0047224MGInjection——
Fosfomycin 500mg Capsule045393500mgCapsuleAdamjee Pharmaceuticals (Pvt) LtdRs 295.92
Fosfomycin 500mg Capsule067425500mgCapsuleSAFE PHARMACEUTICAL (PVT) LTDRs 150.10
Fosfomycin Capsule 500mg020474500mgCapsule——
FOSFOMYCIN CAPSULES 500MG019535500MGCapsule——
FOSFOMYCIN CAPSULES 500MG.043023500MGCapsule——
FOSFOMYCIN INJECTION 1%0047211%Injection——
FOSFOMYCIN INJECTION 1GM0195341GMInjection——
FOSFOMYCIN INJECTION 4GM0047234GMInjection——
Fosfomycin Suspension 250mg020473250mgSuspension——
FOSFOMYCIN SYP004724—Syrup——
FOSFOMYCIN SYRUP 250MG/5ML019536250MG/5MLSyrup——

Why this is not described as a brand

The DRAP register has no separate brand column, so an ingredient name and a trade name look identical in the data. This group is an ingredient: the products below are made by different companies under their own trade names, and no single company owns the word.

How these are grouped

These registrations are grouped by the words in their registered name. Strength, pack size, dosage form and trailing variant words such as Forte, Extra, CF, DS and XR are removed before grouping, so Panadol Tablet, Panadol CF Tablet and Panadol Extra Tablet count as one group. Names that only share a first word but mean different things — for example two companies' unrelated products — can still land together; the registered name of every row is shown so the grouping is checkable.

Source: the bundled DRAP registered-products index and the DRAP price index. Prices are regulatory listings, not pharmacy stock or a retail quote.